These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 31838129)
1. The flanking peptides issue from the maturation of the human islet amyloid polypeptide (hIAPP) slightly modulate hIAPP-fibril formation but not hIAPP-induced cell death. Salazar Vazquez S; Blondeau B; Cattan P; Armanet M; Guillemain G; Khemtemourian L Biochimie; 2020 Mar; 170():26-35. PubMed ID: 31838129 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation. Jaikaran ET; Nilsson MR; Clark A Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847 [TBL] [Abstract][Full Text] [Related]
3. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo. Mo XD; Gao LP; Wang QJ; Yin J; Jing YH Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142 [TBL] [Abstract][Full Text] [Related]
4. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Engel MF; Khemtémourian L; Kleijer CC; Meeldijk HJ; Jacobs J; Verkleij AJ; de Kruijff B; Killian JA; Höppener JW Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6033-8. PubMed ID: 18408164 [TBL] [Abstract][Full Text] [Related]
5. The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity. Esser N; Hogan MF; Templin AT; Akter R; Fountaine BS; Castillo JJ; El-Osta A; Manathunga L; Zhyvoloup A; Raleigh DP; Zraika S; Hull RL; Kahn SE Diabetologia; 2024 Sep; 67(9):1897-1911. PubMed ID: 39245780 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the effects of two major secretory granules components, insulin and zinc, on human-IAPP amyloid aggregation and membrane damage. Khemtemourian L; Antoniciello F; Sahoo BR; Decossas M; Lecomte S; Ramamoorthy A Chem Phys Lipids; 2021 Jul; 237():105083. PubMed ID: 33887213 [TBL] [Abstract][Full Text] [Related]
7. Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus. Caillon L; Hoffmann AR; Botz A; Khemtemourian L J Diabetes Res; 2016; 2016():5639875. PubMed ID: 26636105 [TBL] [Abstract][Full Text] [Related]
9. Myricetin protects pancreatic β-cells from human islet amyloid polypeptide (hIAPP) induced cytotoxicity and restores islet function. Dubey R; Kulkarni SH; Dantu SC; Panigrahi R; Sardesai DM; Malik N; Acharya JD; Chugh J; Sharma S; Kumar A Biol Chem; 2021 Jan; 402(2):179-194. PubMed ID: 33544469 [TBL] [Abstract][Full Text] [Related]
10. Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3. Law E; Lu S; Kieffer TJ; Warnock GL; Ao Z; Woo M; Marzban L Diabetologia; 2010 Jul; 53(7):1415-27. PubMed ID: 20369225 [TBL] [Abstract][Full Text] [Related]
11. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin. Sellin D; Yan LM; Kapurniotu A; Winter R Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100 [TBL] [Abstract][Full Text] [Related]
12. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810 [TBL] [Abstract][Full Text] [Related]
13. Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells. Chatterjee Bhowmick D; Jeremic A J Biol Chem; 2018 Sep; 293(37):14210-14223. PubMed ID: 30012886 [TBL] [Abstract][Full Text] [Related]
14. Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus. Khemtémourian L; Killian JA; Höppener JW; Engel MF Exp Diabetes Res; 2008; 2008():421287. PubMed ID: 18483616 [TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of hypoglycemic agents to target human islet amyloid polypeptide: a key protein involved in amyloid deposition and beta-cell loss. Fortin JS; Benoit-Biancamano MO Can J Diabetes; 2015 Oct; 39(5):373-82. PubMed ID: 25862064 [TBL] [Abstract][Full Text] [Related]
16. [Toxicity reduction of human islet amyloid polypeptide by Trim-Away technique in insulinoma cells]. Gong J; Kong L; Yang L; Nie YZ; Liang Y; Teng CB Yi Chuan; 2020 Jun; 42(6):586-598. PubMed ID: 32694117 [TBL] [Abstract][Full Text] [Related]
17. Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Gurlo T; Ryazantsev S; Huang CJ; Yeh MW; Reber HA; Hines OJ; O'Brien TD; Glabe CG; Butler PC Am J Pathol; 2010 Feb; 176(2):861-9. PubMed ID: 20042670 [TBL] [Abstract][Full Text] [Related]
18. Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide. Smith PE; Brender JR; Ramamoorthy A J Am Chem Soc; 2009 Apr; 131(12):4470-8. PubMed ID: 19278224 [TBL] [Abstract][Full Text] [Related]
19. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction. Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis. Li X; Ma L; Zheng W; Chen T Biomaterials; 2014 Oct; 35(30):8596-604. PubMed ID: 25034964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]